Waseem Qasim

10.6k total citations · 1 hit paper
124 papers, 3.7k citations indexed

About

Waseem Qasim is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Waseem Qasim has authored 124 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 60 papers in Molecular Biology and 51 papers in Genetics. Recurrent topics in Waseem Qasim's work include CAR-T cell therapy research (56 papers), Virus-based gene therapy research (46 papers) and CRISPR and Genetic Engineering (33 papers). Waseem Qasim is often cited by papers focused on CAR-T cell therapy research (56 papers), Virus-based gene therapy research (46 papers) and CRISPR and Genetic Engineering (33 papers). Waseem Qasim collaborates with scholars based in United Kingdom, Germany and Italy. Waseem Qasim's co-authors include Adrian J. Thrasher, Paul Veys, Kimberly Gilmour, Persis Amrolia, Christos Georgiadis, H. Bobby Gaspar, Hong Zhan, Roland Preece, Robert Chiesa and Ulrike Mock and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Waseem Qasim

119 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia

2023 174 citations Robert Chiesa, Christos Georgiadis et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Waseem Qasim

Since Specialization

Citations

This map shows the geographic impact of Waseem Qasim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waseem Qasim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waseem Qasim more than expected).

Fields of papers citing papers by Waseem Qasim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waseem Qasim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waseem Qasim. The network helps show where Waseem Qasim may publish in the future.

Co-authorship network of co-authors of Waseem Qasim

This figure shows the co-authorship network connecting the top 25 collaborators of Waseem Qasim. A scholar is included among the top collaborators of Waseem Qasim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waseem Qasim. Waseem Qasim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia 2025 ·New England Journal of Medicine ·Robert Chiesa, Christos Georgiadis, Hani Rashed, Roland Preece, (unknown), Jan Chu, (unknown), (unknown), (unknown), Stuart Adams, Rebecca Thomas, Kimberly Gilmour, Annie Etuk, Deborah Yallop, David O’Connor, Waseem Qasim	0
2	Clinical development of allogeneic chimeric antigen receptor αβ-T cells 2025 ·Molecular Therapy ·Christos Georgiadis, Roland Preece, Waseem Qasim	3
3	Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in 'off the shelf' chimeric antigen receptor T-cell therapies to widen transplant options 2024 ·Haematologica ·Christos Georgiadis, Lauren Nickolay, Farhatullah Syed, Hong Zhan, Soragia Athina Gkazi, Annie Etuk, Ulrike Mock, Roland Preece, Piotr Cuber, Stuart Adams, Giorgio Ottaviano, Waseem Qasim	2
4	Genome editing of therapeutic T cells 2021 ·PubMed ·Waseem Qasim	1
5	CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity 2020 ·Molecular Therapy — Methods & Clinical Development ·Roland Preece, Andrea Pavesi, Soragia Athina Gkazi, Kerstin A. Stegmann, Christos Georgiadis, Damien Tan, (unknown), Mala K. Maini, Antonio Bertoletti, Waseem Qasim	20
6	Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras 2019 ·Journal of Investigative Dermatology ·Anastasia Petrova, Christos Georgiadis, Roland A. Fleck, (unknown), John A. McGrath, Francesco Dazzi, Wei‐Li Di, Waseem Qasim	15
7	Two column classification of tibial plateau fractures; description, clinical application and reliability 2019 ·Injury ·(unknown), Yufang Zhang, Zhihe Zhao, (unknown), Lin Sha, Decheng Lv, Zhen Zhang, Gang Lv, Yufen Zhang, (unknown), Waseem Qasim, Yanfeng Wang	11
8	Microarray Analysis of Differentially Expressed Profiles of Circular RNAs in a Mouse Model of Intestinal Ischemia/Reperfusion Injury with and Without Ischemic Postconditioning 2018 ·Cellular Physiology and Biochemistry ·Dongcheng Feng, Zhenlu Li, Guangzhi Wang, Jihong Yao, Li Yang, Waseem Qasim, Yongfu Zhao, Xiaofeng Tian	6
9	Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations 2017 ·Blood ·Tie Zheng Hou, Nisha Verma, Jennifer Wanders, Alan Kennedy, Blagoje Soskic, Daniel Janman, Neil Halliday, Behzad Rowshanravan, Austen Worth, Waseem Qasim, Helen Baxendale, Hans J. Stauss, Suranjith L. Seneviratne, Olaf Neth, Peter Olbrich, Sophie Hambleton, Peter D. Arkwright, Siobhan O. Burns, Lucy S. K. Walker, David M. Sansom	71
10	PKCζ phosphorylates TRAF2 to protect against intestinal ischemia–reperfusion–induced injury 2017 ·Cell Death and Disease ·Wei Zhou, Jihong Yao, Guangzhi Wang, Zhao Chen, Zhenlu Li, Dongcheng Feng, Yang Li, Waseem Qasim, Wenzhi Tan, Shili Ning, Xiaofeng Tian	15
11	Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience 2017 ·Biology of Blood and Marrow Transplantation ·Mary Slatter, Kanchan Rao, Intan Juliana Abd Hamid, Zohreh Nademi, Robert Chiesa, Reem Elfeky, Mark S. Pearce, Persis Amrolia, Austen Worth, Terence Flood, Mario Abinun, Sophie Hambleton, Waseem Qasim, H. Bobby Gaspar, Andrew J. Cant, Andrew R. Gennery, Paul Veys	60
12	Adoptive T-Cell Therapy for Cancer in the United Kingdom: A Review of Activity for the British Society of Gene and Cell Therapy Annual Meeting 2015 2015 ·Human Gene Therapy ·David E. Gilham, John Anderson, John S. Bridgeman, Robert E. Hawkins, Mark A. Exley, Hans J. Stauss, John Maher, Martin Pulé, Andrew K. Sewell, Gavin Bendle, Steven Lee, Waseem Qasim, Adrian J. Thrasher, Emma Morris	15
13	Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB 2015 ·Journal of Investigative Dermatology ·Christos Georgiadis, Farhatullah Syed, Anastasia Petrova, Alya Abdul‐Wahab, Su M. Lwin, Farzin Farzaneh, Lucas Chan, (unknown), Roland A. Fleck, Leanne Glover, James R. McMillan, Mei Chen, Adrian J. Thrasher, John A. McGrath, Wei‐Li Di, Waseem Qasim	44
14	Phase I Study Protocol for Ex Vivo Lentiviral Gene Therapy for the Inherited Skin Disease, Netherton Syndrome 2013 ·PubMed ·Wei‐Li Di, Jemima E. Mellerio, (unknown), John Harper, Alya Abdul‐Wahab, (unknown), Lucas Chan, Magdalena Martinez-Queipo, Havinder Hara, Anne‐Marie McNicol, Farzin Farzaneh, John A. McGrath, Adrian J. Thrasher, Waseem Qasim	27
15	Lentiviral Gene Therapy Against Human Immunodeficiency Virus Type 1, Using a Novel Human TRIM21-Cyclophilin A Restriction Factor 2012 ·Human Gene Therapy ·(unknown), Torsten Schaller, Ayad Eddaoudi, Hong Zhan, Choon Ping Tan, (unknown), Adrian J. Thrasher, Greg J. Towers, Waseem Qasim	16
16	Omission of in vivo T‐cell depletion promotes rapid expansion of naïve CD4⁺ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant 2012 ·British Journal of Haematology ·Robert Chiesa, Kimberly Gilmour, Waseem Qasim, Stuart Adams, Austen Worth, Hong Zhan, (unknown), Sophie Derniame, Catherine M. Cale, Kanchan Rao, Prashant Hiwarkar, Rachel Hough, Aurore Saudemont, (unknown), Nick Goulden, Persis Amrolia, Paul Veys	85
17	FOXRED1, encoding an FAD-dependent oxidoreductase complex-I-specific molecular chaperone, is mutated in infantile-onset mitochondrial encephalopathy 2010 ·Human Molecular Genetics ·Elisa Fassone, Andrew Duncan, Jan‐Willem Taanman, Alistair T. Pagnamenta, Michael I. Sadowski, (unknown), Waseem Qasim, Paul Rutland, Sarah E. Calvo, Vamsi K. Mootha, Maria Bitner‐Glindzicz, Shamima Rahman	78
18	Hybrid Lentiviral Vectors 2010 ·Molecular Therapy ·Waseem Qasim, Conrad A. Vink, Adrian J. Thrasher	10
19	Gene therapy for severe combined immune deficiency 2004 ·Expert Reviews in Molecular Medicine ·Waseem Qasim, H. Bobby Gaspar, Adrian J. Thrasher	50
20	The impact of retroviral suicide gene transduction procedures on T cells 2003 ·British Journal of Haematology ·Waseem Qasim, (unknown), (unknown), Stephanie Verfuerth, Christine Kinnon, Adrian J. Thrasher, H. Bobby Gaspar	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact